Skip to content
OpenCapital
Get started

CONMED CNMD Fair Value Measurement Disclosure

Fair Value Measurement Disclosure at other companies

TFX
TeleflexTFX
$47.53M+0.2%
Bausch + Lomb logo
Bausch + LombBLCO
$98M-14.0%
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeLiability.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's fair value measurement disclosure.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's fair value measurement disclosure?
CONMED (CNMD) reported fair value measurement disclosure of $3.83M in Q1 2026.
How has CONMED's fair value measurement disclosure changed year-over-year?
CONMED's fair value measurement disclosure increased by 8.3% year-over-year, from $3.53M to $3.83M.
What is the long-term trend for CONMED's fair value measurement disclosure?
Over 5 years (2020 to 2025), CONMED's fair value measurement disclosure has grown at a -9.0% compound annual growth rate (CAGR), from $9.51M to $5.94M.
What does fair value measurement disclosure mean?
This represents the aggregate carrying amount of assets and liabilities that are measured at fair value on a recurring or non-recurring basis. It provides transparency into the valuation techniques and inputs used to determine these values, categorized by the fair value hierarchy. This is critical for asset managers holding diverse investment portfolios.